Wolverine Trading
TDOC icon

Wolverine Trading’s Teladoc Health TDOC Stock Holding History

Wolverine Trading’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$199K Buy
24,209
+12,370
+104% +$96.5K ﹤0.01% 4931
2025
Q2 		$99.6K Sell
11,839
-28,702
-71% -$208K ﹤0.01% 4165
2025
Q1 		$328K Buy
40,541
+25,671
+173% +$260K ﹤0.01% 3424
2024
Q4 		$138K Sell
14,870
-4,974
-25% -$48K ﹤0.01% 4686
2024
Q3 		$168K Buy
19,844
+7,953
+67% +$65.8K ﹤0.01% 4180
2024
Q2 		$116K Buy
+11,891
New +$145K ﹤0.01% 4027
2024
Q1 		– Sell
-15,613
Closed -$283K – 5279
2023
Q4 		$336K Sell
15,613
-8,328
-35% -$154K ﹤0.01% 3349
2023
Q3 		$445K Buy
23,941
+15,126
+172% +$353K ﹤0.01% 2877
2023
Q2 		$223K Sell
8,815
-13,149
-60% -$331K ﹤0.01% 3416
2023
Q1 		$537K Buy
21,964
+13,299
+153% +$356K ﹤0.01% 2440
2022
Q4 		$205K Buy
+8,665
New +$234K ﹤0.01% 3123
2022
Q2 		– Sell
-73,605
Closed -$5.38M – 5692
2022
Q1 		$5.38M Sell
73,605
-57,468
-44% -$4.14M 0.01% 1037
2021
Q4 		$12.4M Buy
131,073
+126,600
+2,830% +$15.1M 0.01% 628
2021
Q3 		$563K Sell
4,473
-23,293
-84% -$3.39M ﹤0.01% 3755
2021
Q2 		$4.76M Sell
27,766
-59,342
-68% -$9.62M 0.01% 1181
2021
Q1 		$15.2M Buy
87,108
+11,923
+16% +$2.77M 0.02% 504
2020
Q4 		$15.3M Buy
75,185
+23,339
+45% +$4.75M 0.02% 476
2020
Q3 		$11.3M Buy
51,846
+21,990
+74% +$4.66M 0.03% 491
2020
Q2 		$5.59M Sell
29,856
-11,821
-28% -$2.07M 0.02% 745
2020
Q1 		$6.82M Sell
41,677
-46,885
-53% -$5.45M 0.02% 592
2019
Q4 		$7.37M Buy
88,562
+50,022
+130% +$3.81M 0.02% 829
2019
Q3 		$2.56M Sell
38,540
-20,215
-34% -$1.33M 0.01% 1263
2019
Q2 		$3.9M Sell
58,755
-14,396
-20% -$839K 0.01% 1057
2019
Q1 		$4.07M Buy
73,151
+1,432
+2% +$87.4K 0.01% 1012
2018
Q4 		$3.47M Buy
71,719
+51,252
+250% +$3.14M 0.01% 1041
2018
Q3 		$1.77M Buy
+20,467
New +$1.46M ﹤0.01% 1793
2017
Q4 		– Sell
-42,548
Closed -$1.41M – 5459
2017
Q3 		$1.41M Buy
42,548
+25,103
+144% +$823K 0.01% 1599
2017
Q2 		$615K Buy
+17,445
New +$508K ﹤0.01% 2230

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wolverine Trading's TDOC Position: Q3 2025 in Review

Wolverine Trading increased its Teladoc Health (TDOC) stake by 104% in Q3 2025, buying an estimated $96.5K and bringing the position to 24,209 shares worth $199K. The position accounts for ﹤0.01% of the portfolio, ranked #4931.

Wolverine Trading first reported a position in TDOC in Q2 2017 and has held it in 28 quarters since. The position peaked at $15.3M in Q4 2020. 356 funds tracked by Wall St. Rank hold TDOC as of Q3 2025.

  • Wolverine Trading held 24,209 shares of Teladoc Health worth $199K as of Q3 2025.
  • Wolverine Trading bought 12,370 Teladoc Health shares in Q3 2025, an estimated $96.5K.
  • Teladoc Health made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #4931 holding.
  • Wolverine Trading first reported a position in Teladoc Health in Q2 2017 and has held it in 28 quarters since.
  • Wolverine Trading's Teladoc Health position peaked at $15.3M in Q4 2020.
  • 356 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.